medigraphic.com
ISSN 1684-1824 (Electronic)

2021, Number 1

<< Back Next >>

Rev Méd Electrón 2021; 43 (1)

Covid-19: the expected vaccine

Lovo J

Language: Spanish
References: 14
Page:
PDF size: 80.35 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Rourke EJ. Waiting. New England Journal of Medicine. N Engl J Med [Internet]. 2020[citado 01/05/2020]; 382:2184-85. Disponible en: Disponible en: https://doi.org/10.1056/NEJMp2007073

  2. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report -51. [Internet]. [citado 01/05/2020];2020. Disponible en: Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10

  3. World Health Organization (WHO) . Coronavirus disease 2019 (COVID-19) Situation Report -101[Internet]. [citado 01/05/2020];2020. Disponible en: Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200430-sitrep-101-covid-19.pdf?sfvrsn=2ba4e093_2

  4. National Institutes of Health (NIH). COVID-19 Treatment Guidelines Panel. Coronavirus Diseases 2019 (COVID-19). Treatment Guidelines [Internet].[citado02/05/2020];2020. Disponible en: Disponible en: https://www.covid19treat mentguidelines.nih.gov/

  5. Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med [Internet]. 2020 [citado 03/05/2020];27(2):taaa020. Disponible en: https://doi.org/10.1093/jtm/taaa020

  6. De Quadros CA. Vacunas: prevención de enfermedades protección de la salud[Internet]. Rev Inst Med Trop S Paulo[citado02/05/2020];2004;46(5). Disponible en: Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652004000500014

  7. Uddin M, Mustafa F, Rizvi TA, et al. SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. Viruses.2020;12(5): 526. Citado en PubMed;PMID: 32397688

  8. Walls AC, Park YJ, Tortorici MA, et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell [Internet]. 2020[citado 03/05/2020];181(2):281-292. Disponible en: https://doi.org/10.1016/j.cell.2020.02.058

  9. Le TT, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov [Internet]. 2020[citado 03/05/2020];19:305-6. Disponible en: https://doi.org/10.1038/d41573-020-00073-5

  10. World Health Organization (WHO). DRAFT landscape of COVID-19 candidate vaccines [Internet]. EU: World Health Organization[citado 07/05/2020]; 2020. Disponible en: Disponible en: https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines

  11. Liu C, Zhou Q, Li Y, et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases.ACS Central Science [Internet].2020 [citado 08/05/2020];6(3): 315-331. Disponible en: https://doi.org/10.1021/acscentsci.0c00272

  12. Cohen J. Vaccine designers take first shots at COVID-19. Science [Internet]. 2020 [citado 09/05/2020];368(6486):14-16 . Disponible en: https://doi.org/10.1126/science.368.6486.14

  13. Padron-Regalado E. Vaccines for SARS-CoV-2: lessons from other coronavirus strains. Infect Dis Ther.2020Citado en PubMed;PMCID: 7177048

  14. Burton DR, Walker LM. Rational Vaccine Design in the Time of COVID-19. Cell Host & Microbe [Internet]. 2020[citado 10/05/2020]; 27(5):695-698. Disponible en: https://doi.org/10.1016/j.chom.2020.04.022




2020     |     www.medigraphic.com